Acadia Healthcare (NASDAQ:ACHC) Issues Quarterly Earnings Results, Misses Estimates By $0.11 EPS

Acadia Healthcare (NASDAQ:ACHC) announced its quarterly earnings data on Thursday. The company reported $0.64 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.75 by ($0.11), Zacks reports. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. Acadia Healthcare updated its Q1 2025 guidance to EPS and its FY 2025 guidance to 2.500-2.800 EPS.

Acadia Healthcare Stock Performance

Shares of ACHC traded down $0.74 during trading hours on Thursday, reaching $40.26. 2,758,823 shares of the company traded hands, compared to its average volume of 1,440,684. The stock has a market capitalization of $3.74 billion, a P/E ratio of 13.20, a P/E/G ratio of 1.46 and a beta of 1.30. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. Acadia Healthcare has a 12-month low of $36.50 and a 12-month high of $86.67. The business has a fifty day moving average price of $42.22 and a 200-day moving average price of $52.30.

Analyst Ratings Changes

Several analysts have issued reports on ACHC shares. Royal Bank of Canada reissued an “outperform” rating and issued a $64.00 price objective on shares of Acadia Healthcare in a research note on Friday, January 10th. KeyCorp raised shares of Acadia Healthcare from a “sector weight” rating to an “overweight” rating and set a $70.00 price objective on the stock in a report on Tuesday, January 7th. Deutsche Bank Aktiengesellschaft raised shares of Acadia Healthcare from a “hold” rating to a “buy” rating and lifted their price target for the stock from $45.00 to $75.00 in a report on Thursday, December 12th. TD Cowen cut their price target on shares of Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating on the stock in a report on Tuesday, January 7th. Finally, Barclays cut their price target on shares of Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating on the stock in a report on Friday, November 22nd. One research analyst has rated the stock with a sell rating, two have issued a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $70.22.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.